Actinium Pharmaceuticals, Inc. (ATNM)
1.22
+0.03
(+2.52%)
USD |
NYAM |
Sep 18, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Shareholders Equity (Quarterly) : 30.30M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.30M |
| March 31, 2026 | 2.304M |
| December 31, 2025 | 7.834M |
| September 30, 2025 | 13.78M |
| June 30, 2025 | 19.01M |
| March 31, 2025 | 25.69M |
| December 31, 2024 | 32.76M |
| September 30, 2024 | 38.21M |
| June 30, 2024 | 43.84M |
| March 31, 2024 | 43.86M |
| December 31, 2023 | 36.38M |
| September 30, 2023 | 43.58M |
| June 30, 2023 | 53.08M |
| March 31, 2023 | 57.21M |
| December 31, 2022 | 66.48M |
| September 30, 2022 | 71.26M |
| June 30, 2022 | 78.18M |
| March 31, 2022 | 68.84M |
| December 31, 2021 | 73.54M |
| September 30, 2021 | 80.28M |
| June 30, 2021 | 80.50M |
| March 31, 2021 | 70.74M |
| December 31, 2020 | 61.32M |
| September 30, 2020 | 45.43M |
| June 30, 2020 | 50.77M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.02M |
| December 31, 2019 | 5.644M |
| September 30, 2019 | 9.936M |
| June 30, 2019 | 15.70M |
| March 31, 2019 | 5.343M |
| December 31, 2018 | 8.813M |
| September 30, 2018 | 11.58M |
| June 30, 2018 | 17.32M |
| March 31, 2018 | 21.75M |
| December 31, 2017 | 13.67M |
| September 30, 2017 | 18.19M |
| June 30, 2017 | 8.871M |
| March 31, 2017 | 12.88M |
| December 31, 2016 | 18.01M |
| September 30, 2016 | 14.23M |
| June 30, 2016 | 19.08M |
| March 31, 2016 | 20.06M |
| December 31, 2015 | 21.97M |
| September 30, 2015 | 22.89M |
| June 30, 2015 | 23.28M |
| March 31, 2015 | 16.44M |
| December 31, 2014 | -1.922M |
| September 30, 2014 | 2.372M |
| June 30, 2014 | 4.33M |
| March 31, 2014 | -13.47M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.16M |
| Total Liabilities (Quarterly) | 9.855M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 4.076 |
| Net Debt Paydown Yield | 0.06% |